Stockreport

Stifel and Jefferies Raise Targets on Tango Therapeutics (TNGX) [Yahoo! Finance]

Tango Therapeutics, Inc.  (TNGX) 
PDF target on Tango Therapeutics, Inc. (NASDAQ:TNGX) from $15 to $24 while keeping a Buy rating on the stock. The firm pointed to recent progress in PRMT5 inhibitors and R [Read more]